Home › Dementia › NCT07742189

Medication Collaboration Feasibility Study

Feasibility Study of a Brief Intervention to Support Medication Collaboration Among Older Adults and Family Care Partners

Who can join

Ages 60 and older · All sexes

Inclusion Criteria for older adults with dementia:

1. Age 60 or older
2. Diagnosis of dementia, Alzhimer's Disease or Mild Cognitive Impairment
3. Quick Dementia Rating Scale Score 2-12 (inclusive of mild cognitive impairment and mild dementia)
4. Taking 3 or more medications
5. Involved with managing their medications
6. Proficient speaking English
7. Capacity to provide consent

Inclusion criteria for caregivers include::

1. Primary family caregiver for the past 3 months
2. Age 18 or older
3. Proficient speaking English

Exclusion Criteria:

* adults unable to consent

About the study

This study examines the feasibility and acceptability of a brief medication collaboration intervention among older adults (age 60+) with early-stage dementia or mild cognitive impairment who take multiple medications and their family caregivers. The main aims are to: 1) determine the feasibility and acceptability of the intervention for older adults with early-stage dementia and their family caregivers, and 2) explore the effects of intervention on medication collaboration, medication adherence, and beliefs about dementia and autonomy.

In this study, participants will: 1) complete a 15-30-minute baseline interview (by Zoom or phone), 2) participate together in a 45-60-minute virtual intervention led by an interventionist that includes:

Assessment of medication responsibilities and beliefs. Education about dementia and medication management. Cognitive restructuring to address beliefs about independence and caregiver assistance.

Collaborative planning for medication responsibilities and routines; and lastly 3) complete a 15-20-minute one-month follow-up interview (by Zoom or phone) to assess the intervention's acceptability and changes in medication management outcomes.

What is being tested

• Medication Collaboration Intervention (behavioral)

Sponsor: Northwestern University · Participants: 30 · Started: Aug 3, 2026

Contact the study team

• Rachel O'Conor · Phone: 13125033240
• Dianne Oladejo · Phone: 3125036452

Official record on ClinicalTrials.gov — NCT07742189

Locations in the U.S.

Conditions

• Dementia

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.